Smoore International Limited
SMORF | OTC
$1.11
$0.00 (0.00%)
At close: Oct 12, 2026, 04:00 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Dec 31, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 15.35B | 14.26B | 12.77B | 11.8B | 11.12B | 11.2B | 8.4B | 8.94B | 12.46B | 13.76B | 13.08B |
Cost of Revenue | 10.5B | 9.32B | 7.97B | 7.32B | 6.64B | 6.8B | 10.01B | 9.66B | 6.06B | 6.23B | 5.75B |
Gross Profit | 4.86B | 4.93B | 4.8B | 4.48B | 4.44B | 4.37B | -1.61B | -728.69M | 6.39B | 7.52B | 7.33B |
Operating Income | 1.18B | 1.17B | 1.03B | 1.05B | 1.38B | 1.47B | -5.94B | -5.17B | 3.85B | 5.66B | 5.87B |
Interest Income | 575.9M | 614.23M | 614.27M | 654.49M | 735.39M | 569.34M | 318.55M | 326.03M | 495.15M | 497.91M | 280.62M |
Pretax Income | 1.64B | 1.48B | 1.54B | 1.66B | 1.95B | 1.94B | 1.25B | 2.13B | 4.49B | 6.21B | 6.21B |
Net Income | 1.14B | 1.06B | 1.11B | 1.3B | 1.61B | 1.65B | 1.14B | 1.81B | 3.79B | 5.29B | 5.2B |
Selling & General & Admin | 2.06B | 2.2B | 2.24B | 1.85B | 1.43B | 1.39B | 2.21B | 2.3B | 1.4B | 1.06B | 896.58M |
Research & Development | 1.59B | 1.53B | 1.53B | 1.57B | 1.64B | 1.5B | 2B | 1.99B | 1.08B | 707.24M | 462.5M |
Other Expenses | 31.2M | 31.2M | n/a | n/a | 9.88M | 9.88M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 3.68B | 3.76B | 3.78B | 3.43B | 3.09B | 2.88B | 4.81B | 4.82B | 2.4B | 1.78B | 1.36B |
Interest Expense | 25.9M | 12.62M | n/a | n/a | 27.19M | 27.19M | 2.88M | 2.88M | n/a | n/a | n/a |
Selling & Marketing Expenses | 422.08M | 913.31M | 1.04B | 919.55M | 692.1M | 526.24M | 596.33M | 564.4M | 301.37M | 192.92M | 138.42M |
Cost & Expenses | 14.17B | 13.09B | 11.75B | 10.75B | 9.75B | 9.7B | 14.83B | 14.48B | 8.46B | 8.01B | 7.11B |
Income Tax Expense | 503.95M | 414.09M | 430.01M | 351.79M | 340.98M | 291.45M | 109.54M | 321.99M | 695.61M | 922.38M | 1.01B |
Shares Outstanding (Basic) | 6.09B | 6.25B | 6.18B | 6.13B | 6.15B | 6.17B | 6.17B | 6.08B | 6.19B | 6.2B | 6.19B |
Shares Outstanding (Diluted) | 6.14B | 6.25B | 6.19B | 6.13B | 6.15B | 6.17B | 6.17B | 6.08B | 6.19B | 6.2B | 6.19B |
EPS (Basic) | 0.19 | 0.17 | 0.18 | 0.21 | 0.26 | 0.27 | 0.19 | 0.29 | 0.60 | 0.84 | 0.84 |
EPS (Diluted) | 0.19 | 0.17 | 0.18 | 0.21 | 0.26 | 0.27 | 0.19 | 0.29 | 0.60 | 0.84 | 0.84 |
EBITDA | 1.45B | 1.39B | 1.21B | 1.26B | 2.15B | 2.24B | -5.77B | -5.02B | 3.99B | 5.75B | 5.94B |
EBIT | 1.15B | 1.1B | 962.43M | 985.72M | 1.84B | 1.96B | -5.94B | -5.17B | 3.85B | 5.66B | 5.87B |
Depreciation & Amortization | 302.41M | 284.95M | 246.6M | 271.43M | 316.43M | 271.43M | 170.52M | 145.23M | 138.17M | 87.74M | 74.4M |
Add to Watchlist
Select watchlists to add or remove SMORF